Organogenesis Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68621F1021
USD
2.58
-0.06 (-2.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
564.17
482.04
433.14
450.89
467.36
338.30
260.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
564.17
482.04
433.14
450.89
467.36
338.30
260.98
Raw Material Cost
149.11
132.91
123.35
113.40
118.80
92.45
85.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
1.54
2.19
2.01
7.24
11.28
9.00
Selling and Distribution Expenses
298.78
268.92
242.51
259.31
228.82
196.01
190.26
Other Expenses
4.45
4.87
4.22
3.78
2.35
0.88
0.58
Total Expenditure (Excl Depreciation)
492.43
452.10
410.24
412.47
378.36
308.55
290.44
Operating Profit (PBDIT) excl Other Income
71.7
29.900000000000002
22.9
38.4
89
29.8
-29.5
Other Income
2.28
0.02
0.06
-4.21
-0.01
0.10
0.01
Operating Profit (PBDIT)
85.60
47.13
39.83
42.59
93.58
34.98
-20.02
Interest
0.00
1.54
2.19
2.01
7.24
11.28
9.00
Exceptional Items
-11.69
-23.02
-3.80
-2.27
-6.59
2.25
-1.86
Gross Profit (PBDT)
415.06
349.14
309.79
337.49
348.56
245.85
175.60
Depreciation
26.94
25.37
23.45
18.03
16.68
8.18
9.43
Profit Before Tax
46.97
-2.81
10.39
20.28
63.09
17.76
-40.30
Tax
9.94
-3.67
5.45
4.75
-31.12
0.53
0.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37.03
0.86
4.95
15.53
94.20
17.23
-40.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37.03
0.86
4.95
15.53
94.20
17.23
-40.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.03
0.86
4.95
15.53
94.20
17.23
-40.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
300.13
262.90
278.66
265.67
241.34
141.81
55.58
Earnings per share (EPS)
0.15
0.01
0.04
0.12
0.7
0.15
-0.44
Diluted Earnings per share
0.15
0.01
0.04
0.12
0.7
0.15
-0.44
Operating Profit Margin (Excl OI)
9.99%
4.51%
3.77%
6.38%
16.46%
7.89%
-11.29%
Gross Profit Margin
13.1%
4.68%
7.81%
8.5%
17.07%
7.67%
-11.83%
PAT Margin
6.56%
0.18%
1.14%
3.44%
20.16%
5.09%
-15.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 17.05% vs 11.29% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 4,011.11% vs -81.63% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 76.86% vs 18.34% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -100.00% vs -31.82% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Organogenesis Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
564.17
180.35
383.82
212.82%
Other Operating Income
0.00
0.00
0.00
Total Operating income
564.17
180.35
383.82
212.82%
Raw Material Cost
149.11
83.27
65.84
79.07%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
6.25
-6.25
-100.00%
Selling and Distribution Expenses
298.78
91.00
207.78
228.33%
Other Expenses
4.45
-0.62
5.07
817.74%
Total Expenditure (Excl Depreciation)
492.43
174.27
318.16
182.57%
Operating Profit (PBDIT) excl Other Income
71.74
6.08
65.66
1,079.93%
Other Income
2.28
-0.02
2.30
11,500.00%
Operating Profit (PBDIT)
85.60
17.95
67.65
376.88%
Interest
0.00
6.25
-6.25
-100.00%
Exceptional Items
-11.69
-7.88
-3.81
-48.35%
Gross Profit (PBDT)
415.06
97.08
317.98
327.54%
Depreciation
26.94
11.89
15.05
126.58%
Profit Before Tax
46.97
-8.06
55.03
682.75%
Tax
9.94
0.19
9.75
5,131.58%
Provisions and contingencies
0
0
0.00
Profit After Tax
37.03
-8.25
45.28
548.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
37.03
-8.25
45.28
548.85%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.03
-8.25
45.28
548.85%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
300.13
79.29
220.84
278.52%
Earnings per share (EPS)
0.15
-0.14
0.29
207.14%
Diluted Earnings per share
0.15
-0.14
0.29
207.14%
Operating Profit Margin (Excl OI)
9.99%
3.37%
0.00
6.62%
Gross Profit Margin
13.10%
2.12%
0.00
10.98%
PAT Margin
6.56%
-4.57%
0.00
11.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 56.42 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 17.05% vs 11.29% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3.70 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4,011.11% vs -81.63% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.33 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 76.86% vs 18.34% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.99%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024